ArticleRespirology case reports2026
Endobronchial Myoepithelioma With Fluorodeoxyglucose Uptake.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endobronchial Myoepithelioma With Fluorodeoxyglucose Uptake.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myoepitheliomas of the respiratory organs are extremely rare. We report a case of endobronchial myoepithelioma in a 43-year-old woman presenting to hospital with a cough. Chest computed tomography (CT) showed consolidation in the lingular segment of her left upper lobe. She was initially diagnosed as having pneumonia and treated with antibiotics, but her symptoms persisted. We then performed diagnostic bronchoscopy and observed a smooth, elevated lesion obstructing the lingular bronchus. Positron emission tomography/CT revealed a nodule in the lingular bronchus of the left upper lobe with fluorodeoxyglucose (FDG) uptake, while the consolidation had disappeared. Left upper lobectomy was performed, and on the basis of the pathological findings including immunostaining, she was finally diagnosed as having myoepithelioma. There has been no recurrence during an 18-month follow-up. Although myoepithelioma is a rare disease, it should be considered in the differential diagnosis of nodules with FDG uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.